CBOH's Zoey Kernodle and Josh Barrett discuss the nursing faculty pipeline and recent federal funding debates in JAMA Health Forum

Medicare Advantage rates are federal payments to private insurers, and proposed minimal increases for 2027 have raised concerns about potential impacts on benefits for 34 million enrollees.

Made end-to-end in North Carolina, the pill form of Wegovy is the first-ever FDA-approved oral GLP-1 medication for weight loss, launched in January 2026.

A look back at what topics CBOH examined in 2025

Tariffs on medical devices and supplies could strain hospital budgets and increase patient costs. This analysis examines the implications for healthcare access and supply chain stability.

Can tariffs and price controls solve America's pharmaceutical challenges? This brief analysis examines the implications of 2025's major policy shifts for drug pricing, manufacturing, and supply chains.

100% tariff on imported branded or patented pharmaceuticals starting October 1, 2025. Companies already building U.S. manufacturing facilities—either breaking ground or under construction—will be exempt, ensuring their products avoid the tariff. 

This article explores how recent policy changes to Medicaid financing, provider taxes, and eligibility could affect hospital margins, especially in rural areas where hospitals are already financially vulnerable.

This paper by Joshua Barrett (CBOH) and UNC School of Nursing faculty member Cheryl Jones examines nursing tasks in the context of AI-integrated care delivery, offering a conceptual framework to guide future research and practice.

The UNC Center for the Business of Health’s latest white paper distills insights from the 2025 Research Symposium, where leaders from across sectors gathered to address the urgent and complex challenges facing the U.S. healthcare workforce. Drawing on real-world experience and discussion held under Chatham House Rule, the paper surfaces five strategic themes and a series of guiding questions that challenge conventional thinking and reframe how we invest in, support, and sustain a workforce that meets today’s demands—and tomorrow’s needs.

A high-level overview of Medicaid, including who it covers, how it is funded and administered, and why it is a key focus in current federal and state policy discussions.

As the U.S. considers pharmaceutical tariffs, this commentary offers a brief overview of the issue and its possible implications.